ConductScience.org, home

Paper · 41222708

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140542221Implementing health economics for pharmacogenomics research translation in Africa.Commun Med (Lond)2025https://conductscience.org/library/papers/40542221PubMed
230640364Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease.JAMA Neurol2019https://conductscience.org/library/papers/30640364PubMed
330357892Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.Ann Neurol2018https://conductscience.org/library/papers/30357892PubMed
435517045Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson's Disease and Dopaminergic Treatment Adverse Events.Front Aging Neurosci2022https://conductscience.org/library/papers/35517045PubMed
539812497New Multiomic Studies Shed Light on Cellular Diversity and Neuronal Susceptibility in Parkinson's Disease.Mov Disord2025https://conductscience.org/library/papers/39812497PubMed
612011284MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD.Neurology2002https://conductscience.org/library/papers/12011284PubMed
738243775Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.Mov Disord2024https://conductscience.org/library/papers/38243775PubMed
837025429Association of Catechol-O-Methyltransferase Gene Polymorphisms and Haplotypes in the Levodopa-Induced Adverse Events in Subjects with Parkinson's Disease.Indian J Clin Biochem2023https://conductscience.org/library/papers/37025429PubMed
932355309Genome-wide association study identifies zonisamide responsive gene in Parkinson's disease patients.J Hum Genet2020https://conductscience.org/library/papers/32355309PubMed
1039551668Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic review.Parkinsonism Relat Disord2025https://conductscience.org/library/papers/39551668PubMed
1122139623What factors influence motor complications in Parkinson disease?: a 10-year prospective study.Clin Neuropharmacol2012https://conductscience.org/library/papers/22139623PubMed
1236582064Pharmacogenomics-a New Frontier for Individualized Treatment of Parkinson's Disease.Curr Neuropharmacol2023https://conductscience.org/library/papers/36582064PubMed
1329746402Update in therapeutic strategies for Parkinson's disease.Curr Opin Neurol2018https://conductscience.org/library/papers/29746402PubMed
1436342310Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert.Rev Neurol2022https://conductscience.org/library/papers/36342310PubMed
1530363349Pharmacogenetics of Parkinson's Disease in Clinical Practice.Mov Disord Clin Pract2017https://conductscience.org/library/papers/30363349PubMed
1610636440Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?Clin Genet1999https://conductscience.org/library/papers/10636440PubMed
1733848468Parkinson's disease.Lancet2021https://conductscience.org/library/papers/33848468PubMed
1825645960Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.Synapse2015https://conductscience.org/library/papers/25645960PubMed
1919759203A clinico-pathological study of subtypes in Parkinson's disease.Brain2009https://conductscience.org/library/papers/19759203PubMed
2012119748The impact of pharmacogenetics and pharmacogenomics on drug discovery.Nat Rev Drug Discov2002https://conductscience.org/library/papers/12119748PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/41222708/references